World Journal of Urology

, Volume 22, Issue 1, pp 2–14 | Cite as

Clinical epidemiology of testicular germ cell tumors

  • K.-P. DieckmannEmail author
  • U. Pichlmeier
Topic Paper


Clinical epidemiology is sometimes called the basic science of clinical medicine. In terms of the pathogenesis of testicular germ cell tumors (GCTs), clinical epidemiology analyzes suspected risk factors. The present review highlights the risk factors established so far and briefly summarizes those factors currently under investigation. In analogy to the methods of evidence based medicine, this review attributes levels of evidence to each of the putative risk factors. Level I represents highest quality of evidence while level V denotes the lowest level. So far, undescended testis (UDT), contralateral testicular GCT and familial testis cancer are established risk factors attaining high levels of evidence (levels I–III a). In a meta-analysis of 21 studies exploring the association of UDT with GCT risk, an over-all relative risk (RR) of 4.8 (95% confidence interval 4.0–5.7) was found. Contralateral testicular GCT involves a roughly 25-fold increased RR of GCT, while familial testis cancer constitutes a RR of 3–10. Infertility, testicular atrophy, and twin-ship represent risk factors with lesser levels of evidence (level III a). There is also some evidence for HIV infection being a predisposing factor for GCT (level IV a). Scrotal trauma is probably not associated with GCT risk. The estrogen excess theory implies high estrogen levels during the first trimester of pregnancy. As a consequence, primordial germ cells lose track of the normal developmental line and transform into premalignant cells that later become testicular intraepithelial neoplasia (TIN), the precursor of full-blown testicular GCT. Surrogate parameters for high gestational estrogen levels are investigated in case control studies. Such factors are maternal age >30 years, first-born, low birth weight, maternal breast cancer, high sex-ratio of siblings. So far, the sum of evidence is promising but still conflicting (especially for level III b). Another novel theory is the childhood nutrition hypothesis. This concept postulates a modulating or “catalyzing” effect by high dietary intake during childhood on the pathogenesis of testicular GCT. A surrogate parameter of early childhood nutrition is adult height. So far, 12 controlled studies have looked to the possible association of attained height and GCT risk of which six demonstrated a significant association. Thus, the sum of evidence corresponds to level III b. This concept is appealing because it would explain several hitherto unexplained epidemiological features of GCT.


Testicular germ cell neoplasms Clinical epidemiology Meta-analysis Undescended testis Evidence based medicine 


  1. 1.
    Jöckel KH, Stang A (1999) Perspectives of clinical epidemiology in Germany. J Clin Epidemiol 52:375–378CrossRefPubMedGoogle Scholar
  2. 2.
    Fletcher RH, Fletcher SW, Wagner EH (1988) Clinical epidemiology. The essentials, 2nd edn. Williams and Wilkins, BaltimoreGoogle Scholar
  3. 3.
    Petrakis N (1979) Historic milestones in cancer epidemiology. Sem Oncol 6:433–444Google Scholar
  4. 4.
    Wagner G (1988) Grundlagen, Aufgaben und Ziele der epidemiologischen Krebsforschung. Med Welt 39:348–352Google Scholar
  5. 5.
    Adami HO, Trichopoulos D (2002) Concepts in cancer epidemiology and etiology. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of cancer epidemiology. University Press, Oxford, pp 87–112Google Scholar
  6. 6.
    Bokemeyer C, Harstrick A, Schöffski P, Schmoll HJ, Poliwoda H (1992) Keimzelltumoren des Hodens. Epidemiologische und ätiologische Aspekte. Dtsch Med Wochenschr 117:1532–1537PubMedGoogle Scholar
  7. 7.
    Tamimi R, Adami HO (2002) Testicular cancer. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of Cancer Epidemiology. Oxford University Press, Oxford, pp 429–445Google Scholar
  8. 8.
    Buetow SA (1995) Epidemiology of testicular cancer. Epidemiol Rev 17:433–449PubMedGoogle Scholar
  9. 9.
    Senturia YD (1987) The epidemiology of testicular cancer. Br J Urol 60:285–291PubMedGoogle Scholar
  10. 10.
    Upshur REG (2003) Are all evidence-based practices alike? Problems in the ranking of evidence. Can Med Assoc J 169:672–673Google Scholar
  11. 11.
    Oxford Centre for Evidence-Based Medicine (2003) Levels of evidence and grades of recommendation. Scholar
  12. 12.
    Young RH, Scully RE (1990) Testicular tumors. American Society of Clinical Pathologists Press, ChicagoGoogle Scholar
  13. 13.
    Miyata T (1913) Zur Kenntnis der Hodengeschwülste und die Bedeutung des Traumas für ihre Entstehung. Arch Klin Chir 101:426–448Google Scholar
  14. 14.
    Demel R (1926) Chirurgie des Hodens und des Samenstranges. Ferdinand Enke, StuttgartGoogle Scholar
  15. 15.
    Haughey BP, Graham S, Brasure J, Zielezny M, Sufrin G, Burnet WS (1989) The epidemiology of testicular cancer in upstate New York. Am J Epidemiol 130:25–36PubMedGoogle Scholar
  16. 16.
    UK Testicular Cancer Study Group (1994) Social, behavioural and medical factors in the aetiology of testicular cancer: results from the UK study. Br J Cancer 70:513–520PubMedGoogle Scholar
  17. 17.
    Strader CH, Weiss NS, Daling JR (1988) Vasectomy and the incidence of testicular cancer. Am J Epidemiol 128:56–63PubMedGoogle Scholar
  18. 18.
    Heising J, Engelking R (1978) Maligner Hodentumor und Trauma. Ein Beitrag zur Zusammenhangsbegutachtung. Urologe A 17:73–75PubMedGoogle Scholar
  19. 19.
    Merzenich H, Ahrens W, Stang A, Baumgardt-Elms C, Jahn I, Stegmaier C et al. (2000) Sorting the hype from the facts in testicular cancer: is testicular cancer related to trauma? J Urol 164:2143–2144CrossRefPubMedGoogle Scholar
  20. 20.
    Moller H, Prener A, Skakkebaek NE (1996) Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control 7:264–274PubMedGoogle Scholar
  21. 21.
    Gallagher RP, Huchcroft S, Phillips N, Hill GB, Coldman AJ, Coppin C et al. (1995) Physical activity, medical history, and risk of testicular cancer (Alberta and British Columbia, Canada). Cancer Causes Control 6:398–406PubMedGoogle Scholar
  22. 22.
    Forman D, Pike MC, Davey G, Dawson S, Baker K, Chilvers CED et al. (1994) Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group. Br Med J 308:1393–1399Google Scholar
  23. 23.
    Mills PK, Newell GR, Johnson DE (1984) Testicular cancer associated with employment in agriculture and oil and natural gas extraction. Lancet 1:207–210CrossRefPubMedGoogle Scholar
  24. 24.
    Morrison AS (1976) Cryptorchidism, hernia, and cancer of the testis. J Natl Cancer Inst 56:731–733PubMedGoogle Scholar
  25. 25.
    Mustacchi P, Millmore D (1976) Racial and occupational variations in cancer of the testis: San Francisco,1956–65. J Natl Cancer Inst 56:717–720PubMedGoogle Scholar
  26. 26.
    Garland FC, Gorham ED, Garland CF, Ducatman AM (1988) Testicular cancer in US Navy personnel. Am J Epidemiol 127:411–414PubMedGoogle Scholar
  27. 27.
    Van den Eeden SK, Weiss NS, Strader CH, Daling JR (1991) Occupation and the occurrence of testicular cancer. Am J Ind Med 19:327–337PubMedGoogle Scholar
  28. 28.
    Knight JA, Marrett LD, Weir HK (1996) Occupation and risk of germ cell testicular cancer by histologic type in Ontario. J Occup Environ Med 38:884–890CrossRefPubMedGoogle Scholar
  29. 29.
    Bates MN, Fawcett J, Garrett N, Arnold R, Pearce N, Woodward A (2001) Is testicular cancer an occupational disease of fire fighters? Am J Ind Med 40:263–270CrossRefPubMedGoogle Scholar
  30. 30.
    Stang A, Jöckel KH, Baumgardt-Elms C, Ahrens W (2003) Firefighting and risk of testicular cancer: results from a German population-based case-control study. Am J Ind Med 43:291–294CrossRefPubMedGoogle Scholar
  31. 31.
    Ducatman AM, Conwill DE, Crawl J (1986) Germ cell tumors of the testicle among aircraft repairmen. J Urol 136:834–836PubMedGoogle Scholar
  32. 32.
    Ryder SJ, Crawford PI, Pethybridge RJ (1997) Is testicular cancer an occupational disease? A case-control study of Royal Naval personnel. J R Nav Med Serv 83:130–146PubMedGoogle Scholar
  33. 33.
    Foley S, Middleton S, Stitson D, Mahoney M (1995) The incidence of testicular cancer in Royal Air Force personnel. Br J Urol 76:495–496PubMedGoogle Scholar
  34. 34.
    Andersson E, Nilsson R, Toren K (2003) Testicular cancer among Swedish pulp and paper workers. Am J Ind Med 43:642–646CrossRefPubMedGoogle Scholar
  35. 35.
    Marshall EG, Melius JM, London MA, Nasca PC, Burnett WS (1990) Investigation of a testicular cancer cluster using a case-control approach. Int. J Epidemiol 19:269–273Google Scholar
  36. 36.
    Rhomberg W, Schmoll HJ, Schneider B (1995) High frequency of metalworkers among patients with seminomatous tumors of the testis: a case-control study. Am J Ind Med 28:79–87PubMedGoogle Scholar
  37. 37.
    Pollan M, Gustavsson P, Cano MI (2001) Incidence of testicular cancer and occupation among Swedish men gainfully employed in 1970. Ann Epidemiol 11:554–562CrossRefPubMedGoogle Scholar
  38. 38.
    Lipworth L, Dayan AD (1969) Rural preponderance of seminoma of the testis. Cancer 23:1119–1121PubMedGoogle Scholar
  39. 39.
    Clemmesen J (1968) A doubling of morbidity from testis carcinoma in Copenhagen, 1943–1962. Acta Pathol Microbiol Scand 72:348–349PubMedGoogle Scholar
  40. 40.
    Hardell L, Nasman A, Ohlson CG, Fredrikson M (1998) Case-control study on risk factors for testicular cancer. Int J Oncol 13:1299–1303PubMedGoogle Scholar
  41. 41.
    Calvert GM, Fajen JM, Hills BW, Halperin WE (1990) Testicular cancer, dimethylformamide, and leather tanneries (letter). Lancet 336:1253–1254CrossRefGoogle Scholar
  42. 42.
    Levin SM, Baker DB, Landrigan PJ, Monaghan SV, Frumin E, Braithwaite M et al. (1987) Testicular cancer in leather tanners exposed to dimethylformamide. Lancet 2:1153CrossRefPubMedGoogle Scholar
  43. 43.
    Swerdlow AJ, Douglas AJ, Huttly SR, Smith PG (1991) Cancer of the testis, socioeconomic status, and occupation. Br J Ind Med 48:670–674PubMedGoogle Scholar
  44. 44.
    Hayes RB, Brown LM, Pottern LM, Gomez M, Kardaun JW, Hoover RN et al. (1990) Occupation and risk for testicular cancer: a case-control study. Int J Epidemiol 19:825–831PubMedGoogle Scholar
  45. 45.
    Jorgensen N, Giwercman A, Hansen SW, Skakkebaek NE (1993) Testicular cancer after vasectomy: origin from carcinoma in situ of the testis (see comments). Eur J Cancer 29A:1062–1064PubMedGoogle Scholar
  46. 46.
    Forman D, Gallagher R, Möller H, Swerdlow TJ (1990) Aetiology and epidemiology of testicular cancer: report of consensus group. Progr Clin Biol Res 357:245–253Google Scholar
  47. 47.
    Curling TB (1856) Practical treatise on the diseases of the testis and of the spermatic cord and scrotum. (2nd American edn). Blanchard and Lea, PhiladelphiaGoogle Scholar
  48. 48.
    Eccles WMA (1903) The imperfectly descended testis: its anatomy, physiology and pathology. Bailliere, Tindall and Cox, LondonGoogle Scholar
  49. 49.
    Gilbert JB, Hamilton JB (1940) Incidence and nature of tumors in ectopic testes. Surg Gynec Obst 71:731–743Google Scholar
  50. 50.
    Campbell HE (1942) Incidence of malignant growth of the undescended testis. Arch Surg 44:353–369Google Scholar
  51. 51.
    Campbell HE (1959) The incidence of malignant growth of the undescended testicle: a reply and re-evaluation. J Urol 81:663–668PubMedGoogle Scholar
  52. 52.
    Henderson BE, Benton B, Jing J, Yu MC, Pike MC (1979) Risk factors for cancer of the testis in young men. Int J Cancer 23:598–602PubMedGoogle Scholar
  53. 53.
    Pinczowski D, McLaughlin JK, Lackgren G, Adami HO, Persson I (1991) Occurrence of testicular cancer in patients operated on for cryptorchidism and inguinal hernia. J Urol 146:1291–1294PubMedGoogle Scholar
  54. 54.
    Giwercman A, Grindsted J, Hansen B, Jensen OM, Skakkebaek NE (1987) Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol 138:1214–1216PubMedGoogle Scholar
  55. 55.
    Benson RCJr, Beard CM, Kelalis PP, Kurland LT (1991) Malignant potential of the cryptorchid testis. Mayo Clin Proc 66:372–378PubMedGoogle Scholar
  56. 56.
    Swerdlow AJ, Higgins CD, Pike MC (1997) Risk of testicular cancer in cohort of boys with cryptorchidism. Br Med J 314:1507–1511Google Scholar
  57. 57.
    Moller H, Cortes D, Engholm G, Thorup J (1998) Risk of testicular cancer with cryptorchidism and with testicular biopsy: cohort study. Br Med J 317:729–730Google Scholar
  58. 58.
    Coldman AJ, Elwood JM, Gallagher RP (1982) Sports activities and risk of testicular cancer. Br J Cancer 46:749–756PubMedGoogle Scholar
  59. 59.
    Davies TW, Palmer CR, Ruja E, Lipscombe JM (1996) Adolescent milk, dairy product and fruit consumption and testicular cancer. Br J Cancer 74:657–660PubMedGoogle Scholar
  60. 60.
    Depue RH, Pike MC, Henderson BE (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71:1151–1155PubMedGoogle Scholar
  61. 61.
    Morris Brown L, Pottern LM, Hoover RN (1987) Testicular cancer in young men: the search for causes of the epidemic increase in the United States. J Epidemiol Community Health 41:349–354PubMedGoogle Scholar
  62. 62.
    Gershman ST, Stolley PD (1988) A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol 17:738–742PubMedGoogle Scholar
  63. 63.
    Herrinton LJ, Zhao W, Husson G (2003) Management of cryptorchism and risk of testicular cancer. Am J Epidemiol 157:602–605CrossRefPubMedGoogle Scholar
  64. 64.
    Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V (1986) Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol 124:39–52PubMedGoogle Scholar
  65. 65.
    Prener A, Engholm G, Jensen OM (1996) Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 7:14–9PubMedGoogle Scholar
  66. 66.
    Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R (1980) The epidemiology of testicular cancer in young adults. Am J Epidemiol 112:232–246PubMedGoogle Scholar
  67. 67.
    Sigurdson AJ, Chang S, Annegers JF, Duphorne CM, Pillow PC, Amato RJ et al. (1999) A case-control study of diet and testicular carcinoma. Nutr Cancer 34:20–26CrossRefPubMedGoogle Scholar
  68. 68.
    Stang A, Ahrens W, Bromen K, Baumgardt-Elms C, Jahn I, Stegmaier C et al. (2001) Undescended testis and the risk of testicular cancer: importance of source and classification of exposure information. Int J Epidemiol 30:1050–1056CrossRefPubMedGoogle Scholar
  69. 69.
    Strader CH, Weiss NS, Daling JR, Karagas MR, McKnight B (1988) Cryptorchism, orchiopexy, and the risk of testicular cancer. Am J Epidemiol 127:1013–1018PubMedGoogle Scholar
  70. 70.
    Swerdlow AJ, Huttly SR, Smith PG (1987) Testicular cancer and antecedent diseases. Br J Cancer 55:97–103PubMedGoogle Scholar
  71. 71.
    Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L (2000) Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 87:438–443CrossRefPubMedGoogle Scholar
  72. 72.
    Sabroe S, Olsen J (1998) Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: a case-cohort study based on midwives’ records in Denmark. Int J Cancer 78:140–143CrossRefPubMedGoogle Scholar
  73. 73.
    Giwercman A, Bruun E, Frimodt-Moller C, Skakkebaek NE (1989) Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 142: 998–1001PubMedGoogle Scholar
  74. 74.
    Champlin HW (1930) Similar tumors of testis occurring in identical twins. J Am Med Assoc 95:96–97Google Scholar
  75. 75.
    Ondrus D, Kuba D, Chrenova S, Matoska J (1997) Familial testicular cancer and developmental anomalies. Neoplasma 44:59–61PubMedGoogle Scholar
  76. 76.
    Dieckmann KP, Pichlmeier U (1997) The prevalence of familial testicular cancer. An analysis of two patient populations and a review of the literature. Cancer 80:1954–1960CrossRefPubMedGoogle Scholar
  77. 77.
    Forman D, Oliver RT, Brett AR, Marsh SG, Moses JH, Bodmer JG et al. (1992) Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 65:255-262PubMedGoogle Scholar
  78. 78.
    Tollerud DJ, Blattner WA, Fraser MC, Brown LM, Pottern L, Shapiro E et al. (1985) Familial testicular cancer and urogenital developmental anomalies. Cancer 55:1849–1854PubMedGoogle Scholar
  79. 79.
    Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M et al. (1994) Familiality of cancer in Utah. Cancer Res 54:2378–2385PubMedGoogle Scholar
  80. 80.
    Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen AL, Fossa SD (1996) Familial testicular cancer in Norway and southern Sweden. Br J Cancer 73:964–969Google Scholar
  81. 81.
    Polednak AP (1996) Familial testicular cancer in a population-based cancer registry. Urol Int 56:238–240PubMedGoogle Scholar
  82. 82.
    Westergaard T, Olsen JH, Frisch M, Kroman N, Nielsen JW, Melbye M (1996) Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study. Int J Cancer 66:627–631CrossRefPubMedGoogle Scholar
  83. 83.
    Spermon JR, Witjes JA, Nap M, Kiemeney L (2001) Cancer incidence in relatives of patients with testicular cancer in the eastern part of The Netherlands. Urology 57:747–752CrossRefPubMedGoogle Scholar
  84. 84.
    Sonneveld DJ, Sleijfer DT, Schrafford Koops H, Sijmons RH, Van der Graaf WT, Sluiter WJ et al. (1999) Familial testicular cancer in a single-centre population. Eur J Cancer 35:1368–1373CrossRefPubMedGoogle Scholar
  85. 85.
    Dong C, Lönnstedt I, Hemminki K (2001) Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer 37:1878–1785CrossRefPubMedGoogle Scholar
  86. 86.
    Parkin DM, Iscovich J (1997) Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ-cell tumours. Int J Cancer 70:654–660CrossRefPubMedGoogle Scholar
  87. 87.
    Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R et al. (2000) Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 24:197–200CrossRefPubMedGoogle Scholar
  88. 88.
    Osterlind A, Berthelsen JG, Abildgaard N, Hansen SO, Hjalgrim H, Johansen B et al. (1991) Risk of bilateral testicular germ cell cancer in Denmark: 1960–1984. J Natl Cancer Inst 83:1391–1395Google Scholar
  89. 89.
    Colls BM, Harvey VJ, Skelton L, Thompson PI, Frampton CM (1996) Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978–1994. J Clin Oncol 14:2061–2065PubMedGoogle Scholar
  90. 90.
    Hoff Wanderas E, Fossa SD, Tretli S (1997) Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 33:244–252CrossRefPubMedGoogle Scholar
  91. 91.
    Dieckmann KP, Boeckmann W, Brosig W, Jonas D, Bauer HW (1986) Bilateral testicular germ cell tumors. Report of nine cases and review of the literature. Cancer 57:1254–1258PubMedGoogle Scholar
  92. 92.
    Rüther U, Dieckmann KP, Bussar-Maatz R, Eisenberger F (2000) Second malignancies following pure seminoma. Oncology 58:75–82CrossRefPubMedGoogle Scholar
  93. 93.
    Dieckmann KP, Skakkebaek NE (1999) Carcinoma in situ of the testis: a review of biological and clinical features. Int J Cancer 83:815–822Google Scholar
  94. 94.
    Montironi R (2002) Intratubular germ cell neoplasia of the testis: testicular intraepithelial neoplasia. Eur Urol 41:651–654CrossRefPubMedGoogle Scholar
  95. 95.
    Sharpe RM, Skakkebaek NE (1993) Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392–1395PubMedGoogle Scholar
  96. 96.
    Sharpe RM (2003) The “oestrogen hypothesis”—where do we stand now? Int J Androl 26:2–15CrossRefPubMedGoogle Scholar
  97. 97.
    Bosland M (1996) Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. In: Huff J, Boyd J, Barrett JC (eds) Cellular and molecular mechanisms of hormonal carcinogenesis: environmental influences. Wiley-Liss, New York, pp 309–352Google Scholar
  98. 98.
    Ekbom A (1998) Growing evidence that several human cancers may originate in utero. Semin Cancer Biol 8:237–244CrossRefPubMedGoogle Scholar
  99. 99.
    Kristensen P, Andersen A, Irgens LM, Bye AS, Vagstad N (1996) Testicular cancer and parental use of fertilizers in agriculture. Cancer Epidemiol Biomarkers Prev 5:3–9PubMedGoogle Scholar
  100. 100.
    Sharpe RM (1995) Another DDT connection. Nature 375:538–539PubMedGoogle Scholar
  101. 101.
    Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J (1987) Carcinoma in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19–28PubMedGoogle Scholar
  102. 102.
    Loughlin JE, Robboy SJ, Morrison AS (1980) Risk factors for cancer of the testis. N Engl J Med 303:112–113PubMedGoogle Scholar
  103. 103.
    Morris Brown L, Pottern LM, Hoover RN (1986) Prenatal and perinatal risk factors for testicular cancer. Cancer Res 46:4812–4816PubMedGoogle Scholar
  104. 104.
    Strohsnitter WC, Noller KL, Hoover RN, Robboy SJ, Palmer JR, Titus-Ernstoff L et al. (2001)Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 93:545–551CrossRefPubMedGoogle Scholar
  105. 105.
    Henderson BE, Ross RK, Pike MC, Casagrande JT (1982) Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232–3239PubMedGoogle Scholar
  106. 106.
    Henderson BE, Bernstein L, Ross RL, Depue RH, Judd HL (1988) The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer 57:216–218PubMedGoogle Scholar
  107. 107.
    Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE (1986) Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 76:1035–1039PubMedGoogle Scholar
  108. 108.
    Panagiotopoulou K, Katsouyanni K, Petridou E, Garas Y, Tzonou A, Trichopoulos D (1990) Maternal age, parity, and pregnancy estrogens. Cancer Causes Control 1:119–124PubMedGoogle Scholar
  109. 109.
    Richiardi L, Akre O, Bellocco R, Ekbom A (2002) Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer 87:545–550CrossRefPubMedGoogle Scholar
  110. 110.
    Bajdik CD, Phillips N, Huchcroft S, Hill GB, Gallagher RP (2001) Cancer in the mothers and siblings of testicular cancer patients. Can J Urol 8:1229–1233PubMedGoogle Scholar
  111. 111.
    Kroman N, Frisch M, Olsen JH, Westergaard T, Melbye M (1996) Oestrogen-related cancer risk in mothers of testicular-cancer patients. Int J Cancer 66:438–440CrossRefPubMedGoogle Scholar
  112. 112.
    Dieckmann KP, Endsin G, Pichlmeier U (2001) How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer?. A case control study on hormone-related factors. Eur Urol 40:677–684CrossRefPubMedGoogle Scholar
  113. 113.
    Nicholson PW, Harland SJ (1995) Inheritance and testicular cancer. Br J Cancer 71:421–426PubMedGoogle Scholar
  114. 114.
    McKiernan JM, Goluboff ET, Liberson GL, Golden R, Fisch H (1995) Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162:361–363Google Scholar
  115. 115.
    Davies JM (1981) Testicular cancer in England and Wales: some epidemiological aspects. Lancet 1:928–932CrossRefPubMedGoogle Scholar
  116. 116.
    Moller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23:8–13Google Scholar
  117. 117.
    Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574CrossRefPubMedGoogle Scholar
  118. 118.
    Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81:1668–1669Google Scholar
  119. 119.
    Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617–631PubMedGoogle Scholar
  120. 120.
    Dieckmann KP, Pichlmeier U (2002) Is risk of testicular cancer related to body size? Eur Urol 42:564–569CrossRefPubMedGoogle Scholar
  121. 121.
    Kleinteich B, Marx G (1983) Sind große schlanke Männer für Hodenkarzinome disponiert? Med Akt 9:146Google Scholar
  122. 122.
    Petridou E, Roukas KI, Dessypris N, Aravantinos G, Bafaloukos D, Efraimidis A et al. (1997) Baldness and other correlates of sex hormones in relation to testicular cancer. Int J Cancer 71:982–985CrossRefPubMedGoogle Scholar
  123. 123.
    Akre O, Ekbom A, Sparen P, Tretli S. Body size and testicular cancer. J. Natl. Cancer Inst. 2000;92:1093–1096Google Scholar
  124. 124.
    Albanes D (1987) Total calories, body weight, and tumor incidence in mice. Cancer Res 47:1987–1992PubMedGoogle Scholar
  125. 125.
    Garner MJ, Birkett NJ, Johnson KC, Shatenstein B, Ghadirian P, Krewski D (2003) Dietary risk factors for testicular carcinoma. Int J Cancer 106:934–941CrossRefPubMedGoogle Scholar
  126. 126.
    Ganmaa D, Li XM, Wang J, Qin LQ, Wang PY, Sato A (2002) Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int J Cancer 98:262–267CrossRefPubMedGoogle Scholar
  127. 127.
    Bonner MR, McCann SE, Moysich KB (2002) Dietary factors and the risk of testicular cancer. Nutr Cancer 44:35–43CrossRefPubMedGoogle Scholar
  128. 128.
    Walcott FL, Hauptmann M, Duphorne CM, Pillow PC, Strom SS, Sigurdson AJ (2002) A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr Cancer 44:44–51CrossRefPubMedGoogle Scholar
  129. 129.
    Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR (1988) Adult stature and risk of cancer. Cancer Res 48:1658–1662PubMedGoogle Scholar
  130. 130.
    Frankel S, Gunnell DJ, Peters TJ, Maynard M, Smith GD (1998) Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. Br Med J 316:499–504Google Scholar
  131. 131.
    Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23:313–342PubMedGoogle Scholar
  132. 132.
    Cole TJ (2000) Secular trends in growth. Proc Nutr Soc 59:317–324PubMedGoogle Scholar
  133. 133.
    Wikland KA, Luo ZC, Niklasson A, Karlberg J (2002) Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr 91:739–754CrossRefPubMedGoogle Scholar
  134. 134.
    Richiardi L, Askling J, Granath F, Akre O (2003) Body size at birth and adulthood and the risk for germ-cell testicular cancer. Cancer Epidemiol Biomarkers Prev 12:669–673PubMedGoogle Scholar
  135. 135.
    Rasmussen F, Gunnell D, Ekbom A, Hallqvist J, Tynelius P (2003) Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control 14:595–598CrossRefPubMedGoogle Scholar
  136. 136.
    Whittemore AS, Paffenbarger RSJ, Anderson K, Lee JE (1984) Early precursors of urogenital cancers in former college men. J Urol 132:1256–1261PubMedGoogle Scholar
  137. 137.
    Swerdlow AJ, Huttly SRA, Smith PG (1989) Testis cancer: post-natal hormonal factors, sexual behaviour and fertility. Int J Cancer 43:549–553PubMedGoogle Scholar
  138. 138.
    Davies TW, Prener A, Engholm G (1990) Body size and cancer of the testis. Acta Oncol 29:287–290PubMedGoogle Scholar
  139. 139.
    Thune I, Lund E (1994) Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 5:549–556PubMedGoogle Scholar
  140. 140.
    Chinda K, Dhom G, Merkel KHH, Jilg R (1983) Zur geographischen Pathologie der malignen Hodentumoren. Pathologe 4:44–50PubMedGoogle Scholar
  141. 141.
    Weir HK, Marrett LD, Moravan V (1999) Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964–1996. Can Med Assoc J 160:201–205Google Scholar
  142. 142.
    Pharris-Ciurej ND, Cook LS, Weiss NS (1999) Incidence of testicular cancer in the United States: has the epidemic begun to abate? Am J Epidemiol 150:45–46PubMedGoogle Scholar
  143. 143.
    McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97:63–70CrossRefPubMedGoogle Scholar
  144. 144.
    Pearce N, Sheppard RA, Howard JK, Fraser J, Lilley BM (1987) Time trends and occupational differences in cancer of the testis in New Zealand. Cancer 59:1677–1682PubMedGoogle Scholar
  145. 145.
    Swerdlow AJ, Skeet RG (1988) Occupational associations of testicular cancer in south-east England. Br J Ind Med 45:225–230PubMedGoogle Scholar
  146. 146.
    Harding M, Hole D, Gillis C (1995) The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975–89. Br J Cancer 72:1559–1562PubMedGoogle Scholar
  147. 147.
    Stone JM, Cruickshank DG, Sandeman TF, Matthews JP (1991) Laterality, maldescent, trauma and other clinical factors in the epidemiology of testis cancer in Victoria, Australia. Br J Cancer 64:132–138PubMedGoogle Scholar
  148. 148.
    Thornhill JA, Conroy RM, Kelly DG, Walsh A, Fennelly JJ, Fitzpatrick JM (1988) An evaluation of predisposing factors for testis cancer in Ireland. Eur Urol 14:429–433PubMedGoogle Scholar
  149. 149.
    Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE et al. (2000) Risk of testicular cancer in men with abnormal semen characteristics: cohort study. Br Med J 321:789–792CrossRefGoogle Scholar
  150. 150.
    Möller H, Skakkebaek NE (1999) Risk of testicular cancer in subfertile men: case-control study. Br Med J 318:559–562Google Scholar
  151. 151.
    Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN (1995) Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 6:519–524PubMedGoogle Scholar
  152. 152.
    Swerdlow AJ, De Stavola BL, Swanwick MA, Maconochie NE (1997) Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 350:1723–1728CrossRefPubMedGoogle Scholar
  153. 153.
    Swerdlow AJ, Huttly SR, Smith PG (1987) Prenatal and familial associations of testicular cancer. Br J Cancer 55:571–577PubMedGoogle Scholar
  154. 154.
    Li FP, Fraumeni JF (1972) Testicular cancers in children: epidemiologic characteristics. J Natl Cancer Inst 48:1575–1581PubMedGoogle Scholar
  155. 155.
    Beard CM, Benson RCJ, Kelalis PP, Elveback LR (1977) Incidence of malignant testicular tumors in the population of Rochester, Minnesota, 1935 through 1974. Mayo Clin Proc 52:8–10PubMedGoogle Scholar
  156. 156.
    Swerdlow AJ, Huttly SR, Smith PG (1988) Is the incidence of testis cancer related to trauma or temperature? Br J Urol 61:518–21PubMedGoogle Scholar
  157. 157.
    Beard CM, Benson RCJ, Kelalis PP, Elveback LR, Kurland LT (1977) The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clin Proc 52:3–7PubMedGoogle Scholar
  158. 158.
    Prener A, Hsieh CC, Engholm G, Trichopoulos D, Jensen OM (1992) Birth order and risk of testicular cancer. Cancer Causes Control 3:265–272PubMedGoogle Scholar
  159. 159.
    Gilbert JB (1944) Tumors of testis following mumps orchitis. Case report and review of 24 cases. J Urol 51:296–300Google Scholar
  160. 160.
    Giertsen JC (1957) Malignant testicular tumors following mumps orchitis. Acta Pathol Micribiol Scand Sect A 42:7–14Google Scholar
  161. 161.
    Ehrengut W, Schwartau M, Hubmann R (1980) Testikuläre Vorerkrankungen bei Patienten mit Hodentumoren unter besonderer Berücksichtigung der Mumpsorchitis. Urologe A 19:283–288PubMedGoogle Scholar
  162. 162.
    Leyh H (1984) Anamnese und Tastbefund sind die Basis der Frühdiagnostik von Hodentumoren. Med Klin 79:612–615Google Scholar
  163. 163.
    Chilvers CE, Pike MC, Peckham MJ (1987) Torsion of the testis: a new risk factor for testicular cancer. Br J Cancer 55:105–106PubMedGoogle Scholar
  164. 164.
    Zhang ZF, Vena JE, Zielezny M, Graham S, Haughey BP, Brasure J et al. (1995) Occupational exposure to extreme temperature and risk of testicular cancer. Arch Environ Health 50:13–8PubMedGoogle Scholar
  165. 165.
    Karagas MR, Weiss NS, Strader CH, Daling JR (1989) Elevated intrascrotal temperature and the incidence of testicular cancer in noncryptorchid men. Am J Epidemiol 129:1104–1109PubMedGoogle Scholar
  166. 166.
    Moller H, Skakkebaek NE (1996) Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark. Int J Cancer 66:287–293CrossRefPubMedGoogle Scholar
  167. 167.
    Srivastava A, Kreiger N (2000) Relation of physical activity to risk of testicular cancer. Am J Epidemiol 151:78–87PubMedGoogle Scholar
  168. 168.
    Graham S, Gibson R, West D, Swanson M, Burnett W, Dayal H (1977) Epidemiology of cancer of the testis in upstate New York. J Natl Cancer Inst 58:1255–1261PubMedGoogle Scholar
  169. 169.
    Pukkala E, Weiderpass E (2002) Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971–95. Int J Cancer 102:643–648CrossRefPubMedGoogle Scholar
  170. 170.
    Morrison AS (1976) Some social and medical characteristics of Army men with testicular cancer. Am J Epidemiol 104:511–516PubMedGoogle Scholar
  171. 171.
    Knoke JD, Gray GC, Garland FC (1998) Testicular cancer and Persian Gulf War service. Epidemiology 9:648–653PubMedGoogle Scholar
  172. 172.
    Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP (1979) Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 39:284–292PubMedGoogle Scholar
  173. 173.
    Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH et al. (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351:1833–1839CrossRefPubMedGoogle Scholar
  174. 174.
    Powles T, Bower M, Daugaard G, Shamash J, De Ruiter A, Johnson M et al. (2003) Multicenter study of human immunodeficiency virus-related germ cell tumors. J Clin Oncol 21:1922–1927CrossRefPubMedGoogle Scholar
  175. 175.
    Wilson WT, Frenkel E, Vuitch F, Sagalowsky AI (1992) Testicular tumors in men with human immunodeficiency virus. J Urol 147:1038–1040PubMedGoogle Scholar
  176. 176.
    Mbulaiteye SM, Parkin DM, Rabkin CS (2003) Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 17:673–696PubMedGoogle Scholar
  177. 177.
    Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami HO et al. (2003) Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 163:705–711CrossRefPubMedGoogle Scholar
  178. 178.
    Satge D, Sasco AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ (1997) An excess of testicular germ cell tumors in Down’s syndrome: three case reports and a review of the literature. Cancer 80:929–935CrossRefPubMedGoogle Scholar
  179. 179.
    Westergaard T, Andersen PK, Pedersen JB, Frisch M, Olsen JH, Melbye M (1998) Testicular cancer risk and maternal parity: a population-based cohort study. Br J Cancer 77:1180–1185PubMedGoogle Scholar
  180. 180.
    Hoff Wanderas E, Grotmol T, Fossa SD, Tretli S (1998) Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and egister-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 9:475–486CrossRefPubMedGoogle Scholar
  181. 181.
    Mori M, Davies TW, Miyake H, Masuoka H, Kumamoto Y, Tsukamoto T (1990) Maternal factors of testicular cancer: a case-control study in Japan. Jpn J Clin Oncol 20:72–77PubMedGoogle Scholar
  182. 182.
    Moller H, Skakkebaek NE (1997) Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control 8:904–912CrossRefPubMedGoogle Scholar
  183. 183.
    Malone KE, Daling JR (1986) Birth weight and the risk of testicular cancer (letter). J Natl Cancer Inst 77:829–30PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Urologische AbteilungAlbertinen-Krankenhaus
  2. 2.Institut für Medizinische Biometrie und Epidemiologie am Zentrum für Experimentelle MedizinUniversitätsklinikum Hamburg-Eppendorf

Personalised recommendations